Business description: Diaceutics PLC

Diaceutics PLC is a United Kingdom-based technology and solutions provider to pharma and biotech companies. It is engaged in research and development activities in the area of drug development science, precision medicine data and platform software. It provides pharma and biotech companies with an end-to-end commercialization solution for precision medicine through data analytics, scientific and advisory services enabled by its platform DXRX - The Diagnostics Network. It has two separate products and service lines: Insight & Engagement Solutions and Scientific & Advisory Services. Insight & Engagement Solutions includes access to the DXRX platform diagnostic testing data repository to utilize licensed data insight products, such as lab segmentation, physician segmentation, testing rate tracker and physician signal. Scientific Advisory Services comprise a range of services developed to help improve patient care by accelerating the development, delivery and uptake of precision medicine.

Number of employees: 213

Sales by Activity: Diaceutics PLC

Fiscal Period: December 2020 (GBP) 2021 (GBP) 2022 (GBP) 2023 (GBP) 2024 (GBP)

Medical Labs & Research

12.7M 13.94M 19.5M 23.7M 32.16M

Geographical breakdown of sales: Diaceutics PLC

Fiscal Period: December 2020 (GBP) 2021 (GBP) 2022 (GBP) 2023 (GBP) 2024 (GBP)

North America

- 8.46M 14.45M 20.83M 29.54M

Europe

4.24M 3.62M 2.7M 2.47M 1.89M

UK

543K 555K 561K 352K 547K

Asia and Rest of World

- 1.31M 1.79M 45K 181K

Asia

1.88M - - - -

USA

6.04M - - - -

Executive Committee: Diaceutics PLC

Manager TitleAgeSince
Chief Executive Officer 42 2023-12-31
Director of Finance/CFO - 2022-03-17
Compliance Officer - 2022-03-31
Chief Tech/Sci/R&D Officer - 2018-01-31
Chief Tech/Sci/R&D Officer 42 2016-06-30

Composition of the Board of Directors: Diaceutics PLC

Director TitleAgeSince
Chairman 65 2024-09-30
Director/Board Member 42 -
Director/Board Member 42 2024-09-30
Director/Board Member - 2022-03-17
Director/Board Member 55 2023-09-30
Director/Board Member 58 2024-10-28

Shareholders: Diaceutics PLC

NameEquities%Valuation
Gresham House Asset Management Ltd. (Investment Management)
13.01 %
11,041,184 13.01 % 26 M p
Canaccord Genuity Wealth Ltd.
6.633 %
5,630,414 6.633 % 13 M p
Universal-Investment-Gesellschaft mbH (Invt Mgmt)
4.724 %
4,009,764 4.724 % 9 M p
Gresham House Asset Management Ltd.
4.566 %
3,875,911 4.566 % 9 M p
Danske Bank A/S (Investment Management)
4.114 %
3,491,822 4.114 % 8 M p

Company details: Diaceutics PLC

Diaceutics Plc

King's Hall Building

BT9 6GW, Belfast

+

http://diaceutics.com
address Diaceutics PLC(DXRX)

Group companies: Diaceutics PLC

NameCategory and Sector
Medical/Nursing Services
Medical/Nursing Services

Data Processing Services

Change 5d. change 1-year change 3-years change Capi.($)
0.00%-2.99%+6.57%+29.78% 166M
-6.61%-2.04%+219.15%+371.65% 22.6B
+4.87%-3.11%+19.89%+35.25% 4.54B
-0.25%-11.94%+11.44%+166.87% 3.8B
+5.49%-0.54%-12.53%+214.83% 2.53B
-0.18%-1.44%-22.02%-6.63% 2.49B
+4.17%-1.20%+43.88%-7.82% 1.71B
+0.96%-2.91%-15.16%-13.05% 1.69B
+0.24%-8.53%-15.90%-2.34% 1.32B
Average +0.97%-2.55%+26.15%+87.61% 4.54B
Weighted average by Cap. -2.59%-2.42%+123.13%+237.12%
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
1.460GBP
Average target price
2.206GBP
Spread / Average Target
+51.10%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. DXRX Stock
  4. Company Diaceutics PLC